Boston Advisors’s Maxim Integrated Products MXIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-22,709
Closed -$1.08M 682
2017
Q3
$1.08M Hold
22,709
0.02% 351
2017
Q2
$1.02M Sell
22,709
-415
-2% -$19.1K 0.02% 374
2017
Q1
$1.04M Sell
23,124
-921
-4% -$40.4K 0.02% 356
2016
Q4
$927K Sell
24,045
-557,676
-96% -$21.9M 0.02% 369
2016
Q3
$23.2M Sell
581,721
-101,389
-15% -$4M 0.57% 36
2016
Q2
$24.4M Buy
683,110
+95,582
+16% +$3.51M 0.61% 36
2016
Q1
$21.6M Buy
587,528
+128,508
+28% +$4.31M 0.53% 51
2015
Q4
$17.4M Buy
459,020
+359,780
+363% +$13.8M 0.41% 67
2015
Q3
$3.31M Buy
+99,240
New +$3.29M 0.12% 215
2013
Q3
Sell
-52,050
Closed -$1.45M 599
2013
Q2
$1.45M Buy
+52,050
New +$1.58M 0.07% 210

Other funds holding MXIM

Boston Advisors's MXIM Position: Q4 2017 in Review

Boston Advisors sold out of Maxim Integrated Products (MXIM) in Q4 2017, closing a stake of 22,709 shares — an estimated $1.08M sold.

Boston Advisors first reported a position in MXIM in Q2 2013 and held it in 10 quarters. The position peaked at $24.4M in Q2 2016. 495 funds tracked by Wall St. Rank hold MXIM as of Q4 2017.

  • Boston Advisors reported no remaining Maxim Integrated Products position as of Q4 2017 after selling out during the quarter.
  • Boston Advisors sold 22,709 Maxim Integrated Products shares in Q4 2017, an estimated $1.08M.
  • Boston Advisors first reported a position in Maxim Integrated Products in Q2 2013 and held it in 10 quarters.
  • Boston Advisors's Maxim Integrated Products position peaked at $24.4M in Q2 2016.
  • 495 funds tracked by Wall St. Rank held Maxim Integrated Products as of Q4 2017.

Based on Boston Advisors's 13F filing for Q4 2017, filed 24 Jan 2018.